Dhampur
DBOL.NSDhampur Bio Organics Limited Price (DBOL.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
66,387,590
(0)%2023 - Income Statement Summary
| Revenue | 18.39B USD |
| Cost of Revenue | 14.75B USD |
| Gross Profit | 3.65B USD |
| Operating Expenses | 3.65B USD |
| Operating Income | 924.40M USD |
| Other Expenses | 3.00B USD |
| Net Income | 464.90M USD |
Income Statement
Dhampur Bio Organics LimitedCurrency: INR
| YEAR | 2020 | 2021 | 2022 | 2023 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0.00
+0% |
15,268,600,000.00
+0% |
24,075,300,000.00
+58% |
18,394,200,000.00
-24% |
|||||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 11,890,100,000.00 | 18,361,000,000.00 | 14,748,000,000.00 | |||||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
0.00
+0% |
3,378,500,000.00
+0% |
5,714,300,000.00
+69% |
3,646,200,000.00
-36% |
|||||||||||||||
| Gross Profit Ratio | (0.00%) | (0.22%) | (0.24%) | (0.20%) | |||||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 38,100,000.00 | 49,800,000.00 | 0.00 | |||||||||||||||
| General and Administrative | 0.00 | 68,400,000.00 | 104,200,000.00 | 205,500,000.00 | |||||||||||||||
| Selling, General & Admin... | 77,641.00 | 267,900,000.00 | 944,600,000.00 | 642,400,000.00 | |||||||||||||||
| Selling & Marketing Exp... | 0.00 | 199,500,000.00 | 840,400,000.00 | 436,900,000.00 | |||||||||||||||
| Depreciation and Amortiz... | 240,000.00 | 312,900,000.00 | 405,300,000.00 | 494,800,000.00 | |||||||||||||||
| Other Expenses | -22,359.00 | 50,500,000.00 | 248,300,000.00 | 3,003,800,000.00 | |||||||||||||||
| Total Operating Expenses | 100,000.00 | 1,820,900,000.00 | 4,206,500,000.00 | 3,646,200,000.00 | |||||||||||||||
| Cost and Exponses | 100,000.00 | 13,711,000,000.00 | 22,567,500,000.00 | 17,579,000,000.00 | |||||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-100,000.00
+0% |
1,610,500,000.00
-1,610,600% |
1,756,100,000.00
+9% |
924,400,000.00
-47% |
|||||||||||||||
| Operating Income Ratio | (0.00%) | (0.11%) | (0.07%) | (0.05%) | |||||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 5,200,000.00 | 4,800,000.00 | 23,100,000.00 | |||||||||||||||
| Interest Expenses | 0.00 | 298,600,000.00 | 408,400,000.00 | 453,300,000.00 | |||||||||||||||
| Total Other Income/Exp... | 0.00 | -305,100,000.00 | -412,500,000.00 | -269,500,000.00 | |||||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -100,000.00 | 1,903,900,000.00 | 2,161,400,000.00 | 1,585,300,000.00 | |||||||||||||||
| EBITDA ratio | (0.00%) | (0.13%) | (0.09%) | (0.09%) | |||||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -100,000.00 | 1,289,700,000.00 | 1,347,700,000.00 | 654,900,000.00 | |||||||||||||||
| Income Before Tax Ratio | (0.00%) | (0.08%) | (0.06%) | (0.04%) | |||||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -240,000.00 | 270,800,000.00 | 236,700,000.00 | 190,000,000.00 | |||||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -100,000.00
+0% |
1,023,300,000.00
-1,023,400% |
1,111,000,000.00
+9% |
464,900,000.00
-58% |
|||||||||||||||
| Net Income Ratio | (0.00%) | (0.07%) | (0.05%) | (0.03%) | |||||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -23.25 | 15.41 | 16.74 | 7.00 | |||||||||||||||
| Diluted EPS | -23.25 | 15.41 | 16.74 | 7.00 | |||||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 4,301.00 | 66,387,590.00 | 66,387,590.00 | 66,414,286.00 | |||||||||||||||
| Diluted Share Outstanding | 4,301.00 | 66,387,590.00 | 66,387,590.00 | 66,387,590.00 | |||||||||||||||